Глобальный рынок систем решений для контроля инфекций, по продуктам (программное обеспечение и услуги), тип инфекции (инфекции в месте хирургического вмешательства (SSI), инфекции кровотока (BSI), инфекции мочевыводящих путей (UTI), инфекции кровотока, связанные с центральным катетером (CLABSI), инфекции мочевыводящих путей, связанные с катетером (CAUTI) и другие), конечный пользователь (больницы, учреждения долгосрочного ухода, клиники, амбулаторные хирургические центры, академические институты, другие), страна (США, Канада, Мексика, Германия, Италия, Великобритания, Франция, Испания, Нидерланды, Бельгия, Швейцария, Турция, Россия, остальные страны Европы, Япония, Китай, Индия, Южная Корея, Австралия, Сингапур, Малайзия, Таиланд, Индонезия, Филиппины, остальные страны Азиатско-Тихоокеанского региона, Бразилия, Аргентина, остальные страны Южной Америки, Южная Африка, Саудовская Аравия, ОАЭ, Египет, Израиль, остальные страны Ближнего Востока и Африки) Отраслевые тенденции и прогноз до 2028 года
Анализ рынка и аналитика: глобальный рынок систем решений для контроля инфекций
Ожидается, что рынок систем решений по надзору за инфекциями будет расти темпами 13,3% в прогнозируемый период с 2021 по 2028 год. Отчет Data Bridge Market Research о рынке систем решений по надзору за инфекциями содержит анализ и информацию о различных факторах, которые, как ожидается, будут преобладать в течение прогнозируемого периода, а также их влиянии на рост рынка. Рост распространенности инфекций, связанных с оказанием медицинской помощи (HAI), ускоряет рост рынка систем решений по надзору за инфекциями.
Системы надзора за инфекциями относятся к типу систем, которые используются для постоянного мониторинга и управления данными об инфекциях, связанных с оказанием медицинской помощи (HAI), для оценки состояния здоровья населения. Говорят, что раннее выявление заболеваний гарантирует надлежащее выполнение профилактических мер.
The increase in the resistance of microbes towards antibiotics and the high adoption of automation in healthcare settings act as the major factors driving the growth of infection surveillance solutions systems market. The increase in the incidences of hospital-associated infections in a clinical setting including urinary tract infection among others surgical site infections and lack of sanitation accelerate the infection surveillance solutions systems market growth. The rise in the trend of self-medication, increased capacity of IT systems to perform analytic processing and non-adherence to prescribed medication further influences the infection surveillance solutions systems market. Additionally, government initiatives in the form of policies, rise in healthcare expenditure, increasing number of surgeries and research and development activities positively affect the infection surveillance solutions systems market. Furthermore, the integration of cloud-based software and emerging economies extend profitable opportunity to the infection surveillance solutions systems market players in the forecast period of 2021 to 2028.
On the other hand, high cost associated with the software, reluctance among medical professionals to adopt advanced healthcare tools and lack of skilled it professionals to operate act as the factors expected to obstruct the infection surveillance solutions systems market growth. The increase in demand for web-based solutions and mobile platforms and consumer preference towards automation in healthcare facilities are projected to challenge the infection surveillance solutions systems market in the forecast period of 2021-2028.
This infection surveillance solutions systems market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on infection surveillance solutions systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Infection Surveillance Solutions Systems Market Scope and Market Size
The infection surveillance solutions systems market is segmented on the basis of products, infection type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market.
- On the basis of products, the infection surveillance solutions systems market is segmented into software and services.
- On the basis of infection type, the infection surveillance solutions systems market is segmented into surgical site infections (SSI), blood stream infections (BSI), urinary tract infections (UTI), central line-associated bloodstream infections (CLABSI), catheter associated urinary tract infection (CAUTI) and others.
- On the basis of end user, the infection surveillance solutions systems market is segmented into hospitals, long term care facilities, clinics, ambulatory surgical centers, academic institutes and others.
Global Infection Surveillance Solutions Systems Market Country Level Analysis
The infection surveillance solutions systems market is analyzed and market size insights and trends are provided by country, products, infection type and end user as referenced above.
The countries covered in the global infection surveillance solutions systems market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the infection surveillance solutions systems market because of the government initiative and rising incidence of HAIs in the U.S. and Canada. Asia-Pacific is expected to witness the significant growth during the forecast period of 2021 to 2028 because of the improving healthcare infrastructure and rising medical tourism in the region.
The country section of the infection surveillance solutions systems market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
Рынок систем решений по надзору за инфекциями также предоставляет вам подробный анализ рынка для каждой страны по росту расходов на здравоохранение на капитальное оборудование, установленной базы различных видов продуктов для рынка систем решений по надзору за инфекциями, влияния технологий с использованием кривых жизненной линии и изменений в сценариях регулирования здравоохранения и их влияния на рынок систем решений по надзору за инфекциями. Данные доступны за исторический период 2011-2019 гг.
Анализ рыночной доли систем решений для контроля за инфекциями и конкурентной среды
Конкурентная среда рынка систем решений по надзору за инфекциями содержит сведения по конкурентам. Включены сведения о компании, финансы компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, глобальное присутствие, производственные площадки и объекты, производственные мощности, сильные и слабые стороны компании, запуск продукта, широта и широта продукта, доминирование приложений. Приведенные выше данные относятся только к фокусу компаний, связанному с рынком систем решений по надзору за инфекциями.
Основными игроками, охваченными отчетом о рынке систем решений для наблюдения за инфекциями, являются BD, Cerner Corporation, Illumina, Inc., RL Solutions, GOJO Industries, Inc., SC Johnson & Son, Inc., Baxter, Wolters Kluwer, Vigilanz Corporation, IBM Corporation, HyGreen Inc., Premier, Atlas MD, Deb Group Ltd и другие отечественные и мировые игроки. Данные о доле рынка доступны для всего мира, Северной Америки, Европы, Азиатско-Тихоокеанского региона (APAC), Ближнего Востока и Африки (MEA) и Южной Америки отдельно. Аналитики DBMR понимают конкурентные преимущества и предоставляют конкурентный анализ для каждого конкурента отдельно.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 DBMR MARKET CHALLENGE MATRIX
2.9 DBMR VENDOR SHARE ANALYSIS
2.1 MULTIVARIATE MODELING
2.11 PRODUCTS LIFELINE CURVE
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING NUMBER OF HEALTHCARE-ACQUIRED INFECTIONS (HAIS)
3.1.2 INCREASING HEALTHCARE EXPENDITURE
3.1.3 GOVERNMENT POLICIES FOR PREVENTING HEALTH-ACQUIRED INFECTIONS (HAIS)
3.2 RESTRAINTS
3.2.1 HIGH COST OF SOFTWARE
3.2.2 DEARTH OF SKILLED IT PROFESSIONALS IN THE HEALTHCARE INDUSTRY
3.3 OPPORTUNITIES
3.3.1 CLOUD-BASED SOFTWARE OFFERS SIGNIFICANT GROWTH OPPORTUNITIES
3.3.2 HIGH GROWTH IN DEVELOPING COUNTRIES ACROSS ASIA-PACIFIC AND LATIN AMERICA
3.4 CHALLENGE
3.4.1 DATA SECURITY RISK
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS
6.1 OVERVIEW
6.2 SOFTWARE
6.2.1 WEB BASED
6.2.2 ON-PREMISE
6.3 SERVICES
6.3.1 TRAINING & CONSULTING SERVICES
6.3.2 IMPLEMENTATION SERVICES
6.3.3 PRODUCT SUPPORT & MAINTENANCE SERVICES
7 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE
7.1 OVERVIEW
7.2 SURGICAL SITE INFECTIONS (SSI)
7.3 URINARY TRACT INFECTIONS (UTI)
7.4 BLOOD STREAM INFECTIONS (BSI)
7.5 CENTRAL LINE-ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI)
7.6 CATHETER-ASSOCIATED URINARY TRACT INFECTION (CAUTI)
7.7 OTHERS
8 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER
8.1 OVERVIEW
8.2 HOSPITALS
8.2.1 LARGE HOSPITALS
8.2.2 MEDIUM-SIZED HOSPITALS
8.2.3 SMALL HOSPITALS
8.3 CLINICS
8.4 AMBULATORY SURGICAL CENTERS
8.5 LONG TERM CARE FACILITIES
8.5.1 NURSING HOMES
8.5.2 HOMECARE AGENCIES & SERVICES
8.5.3 ASSISTED LIVING FACILITIES
8.6 ACADEMIC INSTITUTES
8.7 OTHERS
9 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY GEOGRAPHY
9.1 OVERVIEW
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.2.3 MEXICO
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 U.K.
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 NETHERLANDS
9.3.7 SWITZERLAND
9.3.8 BELGIUM
9.3.9 RUSSIA
9.3.10 TURKEY
9.3.11 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 CHINA
9.4.2 JAPAN
9.4.3 SOUTH KOREA
9.4.4 INDIA
9.4.5 AUSTRALIA
9.4.6 SINGAPORE
9.4.7 THAILAND
9.4.8 MALAYSIA
9.4.9 INDONESIA
9.4.10 PHILIPPINES
9.4.11 REST OF ASIA-PACIFIC
9.5 SOUTH AMERICA
9.5.1 BRAZIL
9.5.2 REST OF SOUTH AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 SOUTH AFRICA
9.6.2 REST OF MIDDLE EAST & AFRICA
10 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, COMPANY LANDSCAPE
10.1 COMPANY SHARE ANALYSIS: GLOBAL
10.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
10.3 COMPANY SHARE ANALYSIS: EUROPE
10.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
11 SWOT ANALYSIS
11.1 DATA BRIDGE MARKET RESEARCH ANALYSIS
12 COMPANY PROFILES
12.1 WOLTERS KLUWER
12.1.1 COMPANY SNAPSHOT
12.1.2 REVENUE ANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENTS
12.2 BD
12.2.1 COMPANY SNAPSHOT
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHARE ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 ILLUMINA, INC.
12.3.1 COMPANY SNAPSHOT
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHARE ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 CERNER CORPORATION
12.4.1 COMPANY SNAPSHOT
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHARE ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BAXTER
12.5.1 COMPANY SNAPSHOT
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHARE ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 GOJO INDUSTRIES, INC.
12.6.1 COMPANY SNAPSHOT
12.6.2 PRODUCT PORTFOLIO
12.6.3 RECENT DEVELOPMENT
12.7 IBM CORPORATION
12.7.1 COMPANY SNAPSHOT
12.7.2 REVENUE ANALYSIS
12.7.3 PRODUCT PORTFOLIO
12.7.4 RECENT DEVELOPMENT
12.8 RL SOLUTIONS
12.8.1 COMPANY SNAPSHOT
12.8.2 PRODUCT PORTFOLIO
12.8.3 RECENT DEVELOPMENT
12.9 S. C. JOHNSON & SON, INC.
12.9.1 COMPANY SNAPSHOT
12.9.2 PRODUCT PORTFOLIO
12.9.3 RECENT DEVELOPMENT
12.1 VIGILANZ CORPORATION
12.10.1 COMPANY SNAPSHOT
12.10.2 PRODUCT PORTFOLIO
12.10.3 RECENT DEVELOPMENT
13 CONCLUSION
14 QUESTIONNAIRE
15 RELATED REPORTS
Список таблиц
TABLE 1 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 2 GLOBAL SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 3 GLOBAL SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 4 GLOBAL SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 5 GLOBAL SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 7 GLOBAL SURGICAL SITE INFECTIONS (SSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET,BY REGION, 2017-2026 (USD MILLION)
TABLE 8 GLOBAL URINARY TRACT INFECTIONS (UTI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 9 GLOBAL BLOOD STREAM INFECTIONS (BSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 10 GLOBAL CENTRAL LINE-ASSOCIATED BLOOD STREAM INFECTIONS (CLABSI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 11 GLOBAL CATHETER-ASSOCIATED URINARY TRACT INFECTION (CAUTI) IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 12 GLOBAL OTHERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 13 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 14 GLOBAL HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 15 GLOBAL HOSPITAL IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 16 GLOBAL CLINICS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 17 GLOBAL AMBULATORY SURGICAL CENTERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 18 GLOBAL LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 19 GLOBAL LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 20 GLOBAL ACADEMIC INSTITUTES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 21 GLOBAL OTHERS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 22 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY REGION, 2017-2026 (USD MILLION)
TABLE 23 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 24 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 25 NORTH AMERICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 26 NORTH AMERICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 27 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 28 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 29 NORTH AMERICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 30 NORTH AMERICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 31 U.S. SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 32 U.S. SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 33 U.S. SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 34 U.S. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 35 U.S. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 36 U.S. HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 37 U.S. LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 38 CANADA SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 39 CANADA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 40 CANADA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 41 CANADA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 42 CANADA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 43 CANADA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 44 CANADA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 45 MEXICO SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 46 MEXICO SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 47 MEXICO SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 48 MEXICO INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 49 MEXICO INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 50 MEXICO HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 51 MEXICO LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 52 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 53 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 54 EUROPE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 55 EUROPE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 56 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 57 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 58 EUROPE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 59 EUROPE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 60 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 61 GERMANY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 62 GERMANY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 63 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 64 GERMANY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 65 GERMANY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 66 GERMANY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 67 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 68 FRANCE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 69 FRANCE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 70 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 71 FRANCE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 72 FRANCE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 73 FRANCE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 74 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 75 U.K. SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 76 U.K. SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 77 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 78 U.K. INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 79 U.K. HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 80 U.K. LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 81 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 82 ITALY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 83 ITALY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 84 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 85 ITALY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 86 ITALY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 87 ITALY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 88 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 89 SPAIN SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 90 SPAIN SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 91 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 92 SPAIN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 93 SPAIN HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 94 SPAIN LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 95 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 96 NETHERLANDS SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 97 NETHERLANDS SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 98 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 99 NETHERLANDS INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 100 NETHERLANDS HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 101 NETHERLANDS LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 102 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 103 SWITZERLAND SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 104 SWITZERLAND SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 105 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 106 SWITZERLAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 107 SWITZERLAND HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 108 SWITZERLAND LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 109 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 110 BELGIUM SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 111 BELGIUM SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 112 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 113 BELGIUM INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 114 BELGIUM HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 115 BELGIUM LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 116 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 117 RUSSIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 118 RUSSIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 119 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 120 RUSSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 121 RUSSIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 122 RUSSIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 123 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 124 TURKEY SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 125 TURKEY SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 126 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 127 TURKEY INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 128 TURKEY HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 129 TURKEY LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 130 REST OF EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 131 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 132 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 133 ASIA-PACIFIC SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 134 ASIA-PACIFIC SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 135 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 136 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 137 ASIA-PACIFIC HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 138 ASIA-PACIFIC LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 139 CHINA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 140 CHINA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 141 CHINA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 142 CHINA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 143 CHINA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 144 CHINA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 145 CHINA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 146 JAPAN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 147 JAPAN SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 148 JAPAN SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 149 JAPAN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 150 JAPAN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 151 JAPAN HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 152 JAPAN LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 153 SOUTH KOREA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 154 SOUTH KOREA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 155 SOUTH KOREA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 156 SOUTH KOREA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 157 SOUTH KOREA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 158 SOUTH KOREA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 159 SOUTH KOREA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 160 INDIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 161 INDIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 162 INDIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 163 INDIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 164 INDIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 165 INDIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 166 INDIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 167 AUSTRALIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 168 AUSTRALIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 169 AUSTRALIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 170 AUSTRALIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 171 AUSTRALIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 172 AUSTRALIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 173 AUSTRALIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 174 SINGAPORE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 175 SINGAPORE SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 176 SINGAPORE SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 177 SINGAPORE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 178 SINGAPORE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 179 SINGAPORE HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 180 SINGAPORE LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 181 THAILAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 182 THAILAND SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 183 THAILAND SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 184 THAILAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 185 THAILAND INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 186 THAILAND HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 187 THAILAND LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 188 MALAYSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 189 MALAYSIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 190 MALAYSIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 191 MALAYSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 192 MALAYSIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 193 MALAYSIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 194 MALAYSIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 195 INDONESIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 196 INDONESIA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 197 INDONESIA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 198 INDONESIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 199 INDONESIA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 200 INDONESIA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 201 INDONESIA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 202 PHILIPPINES INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 203 PHILIPPINES SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 204 PHILIPPINES SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 205 PHILIPPINES INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 206 PHILIPPINES INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 207 PHILIPPINES HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 208 PHILIPPINES LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 209 REST OF ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 210 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 211 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 212 SOUTH AMERICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 213 SOUTH AMERICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 214 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 215 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 216 SOUTH AMERICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 217 SOUTH AMERICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 218 BRAZIL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 219 BRAZIL SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 220 BRAZIL SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 221 BRAZIL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 222 BRAZIL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 223 BRAZIL HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 224 BRAZIL LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 225 REST OF SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 226 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY COUNTRY, 2017-2026 (USD MILLION)
TABLE 227 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 228 MIDDLE EAST AND AFRICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 229 MIDDLE EAST AND AFRICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 230 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 231 MIDDLE EAST AND AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 232 MIDDLE EAST AND AFRICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 233 MIDDLE EAST AND AFRICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 234 SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 235 SOUTH AFRICA SOFTWARE IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
TABLE 236 SOUTH AFRICA SERVICES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS 2017-2026 (USD MILLION)
TABLE 237 SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY INFECTION TYPE, 2017-2026 (USD MILLION)
TABLE 238 SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 239 SOUTH AFRICA HOSPITALS IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 240 SOUTH AFRICA LONG TERM CARE FACILITIES IN INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY END USER, 2017-2026 (USD MILLION)
TABLE 241 REST OF MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET, BY PRODUCTS, 2017-2026 (USD MILLION)
Список рисунков
FIGURE 1 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SEGMENTATION
FIGURE 2 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DATA VALIDATION MODEL
FIGURE 3 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: GLOBAL VS REGIONAL ANALYSIS
FIGURE 5 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: THE MARKET CHALLENGE MATRIX
FIGURE 9 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGE OF THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET
FIGURE 11 HEALTHCARE EXPENDITURE IN FEW COUNTRIES (2015 & 2016)
FIGURE 12 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SEGMENTATION
FIGURE 13 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE INCREASING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 14 INCREASING NUMBER OF HEALTHCARE-ACQUIRED INFECTIONS (HAIS) AND INCREASING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 15 SOFTWARE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN 2019 & 2026
FIGURE 16 NORTH AMERICA IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET IN THE FORECAST PERIOD OF 2019 TO 2026
FIGURE 17 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS, 2018
FIGURE 18 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY INFECTION TYPE, 2018
FIGURE 19 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY END USER, 2018
FIGURE 20 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 21 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY GEOGRAPHY (2018)
FIGURE 22 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY GEOGRAPHY (2019 & 2026)
FIGURE 23 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY GEOGRAPHY (2018 & 2026)
FIGURE 24 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 25 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 26 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 27 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 28 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 29 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 30 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 31 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 32 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 33 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 34 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 35 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 36 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 37 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 38 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 39 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 40 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 41 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 42 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 43 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 44 SOUTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 45 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: SNAPSHOT (2018)
FIGURE 46 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018)
FIGURE 47 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2019 & 2026)
FIGURE 48 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY COUNTRY (2018 & 2026)
FIGURE 49 MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: BY PRODUCTS (2019-2026)
FIGURE 50 GLOBAL INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
FIGURE 51 NORTH AMERICA INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
FIGURE 52 EUROPE INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
FIGURE 53 ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION SYSTEMS MARKET: COMPANY SHARE 2018 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
